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1. Introduction  
Absence of the cystic fibrosis transmembrane regulator (CFTR) function leads to chronic lung 
disease characterized by inflammation and persistent infections. The mechanisms for the 
increased susceptibility of the respiratory tract for infections in CF are most likely complex and 
only partially understood. Most attention has been focused on the effect of the defective 
expression of CFTR in epithelial cells and submucosal gland cells and the increased 
susceptibility of the respiratory tract to infections was was mostly thought to be related to the 
abnormal chloride channel function (Welsh MJ, 2011, Ratjen F 2003). However, numerous 
studies over the past years have shown that the absence of CFTR affects the immune system 
and that dysfunctional immune responses contribute to pathological processes in the CF lung. 
In addition, it has become increasingly evident that the chloride channel dysfunction alone 
cannot completely explain the pathology of CF lung disease and that other pathways known 
to be regulated by CFTR play a role in the immune dysregulation in the CF lung (Mehta A 
2008). This chapter reviews both soluble factors in the CF milieu that modify immune cell 
function and specific alterations in the cellular components of the innate and adaptive immune 
system that contribute to the impaired immune defense in CF lung disease.  
2. The role of immune responses in CF 
Innate host defenses are defective in CF. It is still not entirely clear how defective CFTR 
results in an impaired host response in the CF lung. Three general components comprise the 
innate and adaptive immune defenses in the respiratory tract: (1) the mucociliary escalator; 
(2) a humoral component of surfactant proteins, defensins, and other antimicrobial 
compounds; and (3) a cellular component that includes epithelial cells, neutrophils, 
macrophages, monocytes, dendritic cells, and lymphocytes. 
2.1 Abnormal humoral responses in CF 
The respiratory tract epithelium and the cells of the submucosal glands in the airways constitute 
a major part of the innate immune defense system of the lung that responds primarily to 
incoming pathogens with the release of various mediators. They are influenced and/or 
amplified in their responses by factors such as cytokines derived from neighboring 
inflammatory and immune cells (Bartlett J 2008). The defective chloride channel function in CF 
leads to alterations in the physical properties of the airway mucus and the composition of the 
airway surface liquid that are linked to impairment of innate defense mechanisms. These affect 
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the shield of antimicrobial factors such as lysozyme, lactoferrin, defensins, and other 
antimicrobial peptides, as well as disturb the mechanical clearance of inhaled particles and 
pathogens by the mucociliary escalator. Table 1 summarizes the known alterations in soluble 
innate immune factors in the CF lung. One school of thought has pursued the concept that 
alterations in the chloride secretion and sodium hyperabsorption in the airways lead to the 
subsequent entrapment of pathogens that then lead to recruitment and activation of neutrophils 
and macrophages. This has also been supported by the lung phenotype of a mouse model with 
genetic over-expression of the sodium channel ENac that mimics CF with thick mucus and 
inflammation in the absence of infection (Mall MA 2010). Salt-sensitive antimicrobials such as 
defensins were initially thought to be defective in the human CF lung. However, as the exact 
concentrations of chloride and sodium in the airway liquid are still not entirely clear, and so the 
degree of impairment of these innate defense mechanisms in CF is not exactly known.  
 
Mediator Abnormality Reference 
Defensins Impaired activity 
Goldman MJ et al. 1997, Bals R et al. 
2001 
Surfactant proteins Decreased or inactive 
Hartl D, Griese M 2006, Meyer KC et 
al. 2000, Noah TL et al. 2003 
Antioxidants 
Reduced glutathione 
availability in airways 
Gao L et al. 1999, Roum JH et al. 1993, 
Day BJ 2005, Childers M et al. 2007, 
Hudson VM 2001 
Opsonins Proteolytic degradation Eichler I et al. 1989 
Cytokines   
IFN-1 Decreased secretion Moss RB et al.1996 and 2000 
IL-12 Increased secretion  Bonfield TL et al. 1995 
IL-43 Increased secretion 
Moss RB et al.1996 and 2000, Mueller C 
et al.2010 
IL-64 Increased secretion  
Black HR et al. 1998, Becker MN et al. 
2004, Andersson C et al. 2007, 
Vandivier RW et al. 2009,  
IL-85 Increased secretion  
Bonfield TL et al. 1995, Black HR et al. 
1998, Becker MN et al. 2004, Vandivier 
RW et al. 2009,  
IL-106 Altered secretion 
Bonfield TL et al. 1995, Moss RB et al. 
1996 and 2000, Armstrong DS et al. 
2005 
IL-137 Increased secretion Mueller C et al.2010 
IL-178 Increased secretion 
McAllister F et al.2005, Tan HL et 
al.2011 
TNF- 9 Increased secretion Bonfield TL et al. 1995, Andersson C et 
al. 2007, 
Chemokines   
MIP-110 Increased secretion Brennan S et al. 2009 
MCP-111 Increased secretion Brennan S et al. 2009 
Notes: 1 IFN-( interferon-gamma); 2 IL-1(interleukin-1 beta), 3 IL-4 (interleukin-4), 4 IL-6 (interleukin-
6), 5 IL-8 (interleukin-8), 6 IL-10 (interleukin-10), 7 IL-13 (interleukin-13), 8 IL-17(interleukin-17), 9 TNF-( 
tumor necrosis factor-alpha), 10 MIP-1(macrophage inflammatory protein-1 beta), 11 MCP-1 
(macrophage chemotactic protein-1) 
Table 1. Altered humoral mediators in the respiratory tract in CF 
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2.1.1 Soluble mediators 
Numerous humoral factors that affect pulmonary innate immune response have been 
studied in the CF lung. These include the collectins and surfactant proteins (Hartl D 2006, 
Noah TL 2003, Meyer KC 2000), defensins (Goldman MJ 1997, Bals 2001), glutathione (Gao 
TJ 1999, Kogan I 2003, Roum JH 1993, Hudson VM 2001) and antiproteases such as secretory 
leukoprotease inhibitor (SLPI) and tissue inhibitor of metalloproteinase 1 (TIMP-1) (Gaggar 
2007, Cantin AM 1991, Vandivier 2002). Initially, it was thought that defensins in the CF 
lung were impaired due to the altered salt concentration in the CF airway (Goldmann 1997). 
Subsequent studies showed the impairment of defensins is not only related to an altered salt 
concentration, but also to increased inflammation (Bals 2001, Chen CI 2004). The Levels of -
defensin were even found to be similar in bronchial brushings in CF and non CF patients 
(Dauletbaev N 2002). Surfactant proteins, besides their surface-tension regulating properties, 
also have immuno-modulatory and anti-inflammatory functions were shown to be 
degraded (Hartl D 2006, Noah TL 2003) and  structurally altered in CF (Meyer KC 2000). 
Glutathione, a critical component of the antioxidant defense system in the lung, was found 
to be reduced in the CF lung (Roum JH 1993). Importantly, this seemed to be directly related 
to the function of CFTR as a channel for the transmembrane transport of glutathione (Gao 
1999, Kogan 2003). As glutathione deficiency also leads to activation of nucleic factor kappa 
B (NFB)-mediated inflammation, aerosolized glutathione has been studied as a potential 
anti-inflammatory therapeutic in CF (Roum 1999).  
Antiprotease, which plays an important role in the lung to counter the proteolytic products 
released by activated neutrophils, did not seem to be altered in the CF lung at baseline 
(Cartin AM 1991). However, these normal baseline levels were probably insufficient to 
neutralize the massive invasion of neutrophils and have thus been considered to be 
relatively deficient in the CF lung. 
2.1.2 Defective CFTR leads to release of inflammatory cytokines 
One of the dominant features of CF lung disease is the exaggerated inflammatory response. 
Numerous studies have linked the CFTR defect to activation of inflammatory cytokines, in 
particular interleukin-8 (IL-8). IL-8 is closely related to the CF inflammation as it is one of 
the major chemoattractants for neutrophils. Neutrophils dominate the inflammatory milieu 
in the CF lung. The importance of the vast number of neutrophils has been underscored by 
the successful use of recombinant DNAse to break down DNA released from neutrophils as 
one of the few effective therapeutics to ameliorate CF lung disease (Suri R 2002). Although it 
is still debated if inflammation precedes infection in the lungs of infants and young children 
with CF, it is undisputed that CFTR is linked to the NFB pathway, a crucial transcription 
activator for inflammatory and immune responses. These intrinsic activations of NFB and 
cytokines, such as IL-8 and tumor necrosis factor alpha (TNF-), have been observed both in 
naïve lung macrophages from CFTR knockout mice (CF mice) and in un-stimulated human 
macrophages with decreased CFTR expression (Bruscia EM 2008, Xu Y 2010). It seems that 
the intrinsic activation of NFB-mediated inflammatory cytokine release is independent of 
the chloride channel function of the CFTR protein. Neutrophil elastase and other products of 
neutrophils, that are abundant in the CF lung, also induce IL-8 expression in epithelial cells 
(McElvaney NG 1992). Besides an increase in inflammatory cytokines, the CFTR defect has 
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also been associated with a decrease in the anti-inflammatory cytokine interleukin-10 (IL-
10). Increased susceptibility to CF pathogens such as Pseudomonas aeruginosa (P. aeruginosa) 
has been demonstrated in IL-10 deficient mice (Soltys J 2002). 
2.2 Abnormal cellular immune response in CF 
Cells of the innate and adaptive immune system have been studied in CF. The main findings 
are outlined in Table 2. As the role of epithelial cells in CF will be discussed in other 
chapters, the following details the functions and abnormalities seen in the neutrophils, 
macrophages, monocytes, dendritic cells, and lymphocytes that are likely playing a part in 
the pathogenesis of CF lung disease.  
2.2.1 Neutrophils 
Neutrophils are the dominating cell type in the inflammatory milieu of the CF airways. The 
content of their granules and products, in particular DNA and neutrophil elastase, 
contribute significantly to the CF lung damage. The increase in the serum and lung cytokine 
levels, especially of IL-8, preactivates neutrophils and lowers their threshold for granule 
release (Swain SD 2002). A number of abnormalities have been observed in CF neutrophils, 
including defective phagocytosis and oxidative burst (Alexis NE 2006), increased 
degranuation (myeloperoxidase) (Koller DY 1995), augmented proteolytic activity with 
elevated elastase and matrix metalloprotein release (Brockbank S 2005, Ratjen F 2002, Sagel 
SD 2005), increased apoptosis and chemotaxis (Brennan S 2001, Watt AP 2005), decreased 
acidification of phagolysosomes and reduced antimicrobial activity (Painter RG 2006), 
defective protein kinase C (Graff I 1991), and dysregulated cytokine secretion (Corvol H 
2003).Blood neutrophils from CF patients were impaired in chlorination of ingested bacteria 
due to defective hypochlorous acid (HOCl) production within phagolysosomes, whereas 
extracellular HOCl production was normal (Painter RG 2006). Profound functional and 
signaling changes have been shown in viable inflammatory neutrophils collected from 
airways of CF patients compared to their blood counterparts (Tirouvanziam R 2007). On CF 
airway neutrophils, the surface expression of phagocytosis receptors CD16 and CD14 was 
lost, whereas other lineage markers such as CD80 and MHCII appeared, indicating potential 
functional reprogramming (Tirouvanziam R 2007). 
The study by Hartl D et al. has provided another pathophysiologic mechanism showing 
unopposed proteolytic cleavage of chemokine receptor CXCR1 on CF neutrophils and 
subsequent failure of their bacterial-killing capacity (Hartl D 2007). One of the most 
important features of the neutrophils in CF is their delayed apoptosis, which could be even 
measured in CF heterozygous individuals (Moriceau S 2010). 
Toll-like receptors (TLRs) play crucial roles in the innate host defense against P. aeruginosa 
Neutrophils express all human TLRs except for TLR3. TLR2 and TLR5 present the main 
TLRs for the recognition of P. aeruginosa. TLR2 and TLR4 are involved in the cytokine 
response to P. aeruginosa infection. Intact flagellin/TLR5 signaling is a prerequisite for an 
efficient clearance of acute P. aeruginosa infection. The expression levels of TLRs in CF 
neutrophils have been investigated (Koll B 2008, Petit-Bertron AF 2008). Circulating and 
airway neutrophils from CF patients displayed a distinct pattern of surface markers as 
compared to the cells from healthy controls (Petit-Bertron AF 2008). CF blood neutrophils 
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Cell type Function Reference
Epithelial cells Bacterial killing Moskwa P et al. 2007
 
Transport of GSH1 
Redox balance
Velsor LW et al. 2001
Xu Y et al. 2006
 Cytokine production Tabary O et al. 2000
Neutrophils Phagocytosis 
Morris MR et al. 2005, Alexis NE et al. 
2006
 Degranulation 
Gaggar A et al. 2007, Koller DY et al. 1995, 
Brockbank S et al. 2005, Ratjen F et al. 
2002, Sagel SD et al. 2005
 Apoptosis 
Vandivier RW et al. 2002, Watt AP et al. 
2005




Painter RG et al. 2006 
 Anti-microbial activity 
Painter RG et al. 2006, Moraes TJ et al. 
2006
 Cytokine production 
Corvol H et al. 2003, Tirouvanziam R et 
al. 2007
 CXCR12 cleavage Hartl D et al. 2007
 TLR3-2, 4, 5 expression Petit Bertron AF et al. 2008
Macrophages Clearance of apoptotic cells Vandiview RW et al. 2002a, 2002b 
 Cytokine production 
Bonfield TL et al. 1995, Bruscia EM et al. 
2009, Brennan S et al. 2009, Xu Y et al. 
2010
 Phagocytosis Knight RA et al. 1997, Di A et al. 2006 
 Acidification of lysosomes 
Di A et al. 2006, Haggie PM, Verkman AS 
2007 and 2009
 Antigen presentation Knight RA et al. 1997
 PPAR4/LXR5 regulation Andersson C et al. 2007
Dendritic cells 
CD1d-restricted natural killer 
T cells activation
Rzemienaik SE et al. 2010 
 Differentiation and maturation Xu Y et al. 2009
 
Activation, antigen presentation, 
and cytokine secretion
Roghanian A et al. 2006, Xu Y et al. 2009 
Monocytes Phagocytosis del Fresno C et al. 2009
 Antigen presentation Sorio C et al. 2011
 MHCII expression del Fresno C et al. 2008
 TREM-16 expression del Fresno C et al. 2008
 Cytokine production del Fresno C et al. 2008
 Toll-2, 4 expression Sturge N C et al. 2010
Lymphocytes Chloride channel function 
McDonald TV et al.1992, Dong YJ et 
al.1995, Moss RB et al.1996
 Cytokine production 
Knutsen AP et al.1989 and 1990, Lahat N 
et al.1989, Moss RB et al.1996 and 2000, 
Hubeau C et al.2004, Hartl D et al.2005 
Muller C et al.2010, Tan HL et al.2011 
Notes: 1 GSH (glutathione); 2 CXCR (C-X-C chemokine receptor), 3 TLR (toll like receptor), 4 PPAR 
(peroxisomal proliferator activated receptors), 5 LXR (liver X receptors), 6 TREM-1 (triggering receptor 
expressed on myeloid cells-1) 
Table 2. Cellular immune dysfunction in CF 
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expressed elevated levels of CD64, an activation marker, and lower levels of TLR2 compared 
to blood neutrophils from healthy controls (Petit-Bertron AF 2008). In contrast, CF airway 
neutrophils expressed an elevated level of TLR4 and spontaneously released IL-8 that was 
neither enhanced by microbial activators nor inhibited by recombinant human IL-10, 
indicating intrinsic resistance to anti-inflammatory signals delivered by IL-10 (Petit-Bertron 
AF 2008). A similar study by Koller B et al. investigated the expression levels of TLR2, TLR4, 
TLR5, and TLR9 on airway neutrophils compared to circulating neutrophils in CF patients 
infected with P. aeruginosa. TLR5 was the only TLR that was significantly higher expressed 
in CF airway neutrophils compared to the controls (Koller B 2008).  
2.2.2 Macrophages 
Alveolar macrophages (AM) are important as a first line host defense in the lung. Besides the 
phagocytosis of inhaled pathogens and apoptotic cells and the release of inflammatory 
mediators they play an important role in orchestrating innate immune defenses (Takabayshi 
2006). One of the important regulatory functions of AM may be to dampen immune responses 
(Lambrecht 2006), so that dysfunction of AM in CF could be related to increased inflammation. 
The antigen-presenting capacity of AM is low, compared to other macrophages and a majority 
of their function is related to phagocytosis. Dysfunctional CFTR in macrophages has been 
linked to impaired clearance of apoptotic cells, pro-inflammatory cytokines production, 
deficient antigen presentation, abnormal TLR4 trafficking, decreased bactericidal activity, and 
defective phagocytosis (Bonfield TL 1995, Bruscia EM 2009 and 2011, del Porto P 2011, Di A 
2006, Knight RA 1997, Vandivier RW 2002a and 2002b, Xu Y 2010). Lipopolysaccharide (LPS) 
stimulated peritoneal macrophages from CF mice showed increased TNF- and IL-6 secretion 
as well as NFB p65 activity. It also demonstrated attenuated induction of peroxisomal 
proliferator activated receptors (PPAR) and liver X receptors (LXR), those are two mediators 
known as the inhibitory regulators of pro-inflammatory cytokines (Andersson C 2007). Bruscia 
et al. showed that macrophages directly contributed to the exaggerated inflammatory response 
following LPS administration in CF mice with increased secretion of cytokines including IL-6 
and keratinocyte chemoattractant (Bruscia EM 2009). The same group also demonstrated that 
abnormal trafficking and degradation of TLR4 might underlie the elevated inflammatory 
response in CF (Bruscia EM 2011). Macrophages isolated from lavage samples from CF 
patients were not able to stimulate allogeneic lymphocytes and to present antigen, while 
peripheral blood monocytes from the same patients were functional in both assays (Knight RA 
1997). Macrophages derived from peripheral blood from CF patients did not differ in 
phagocytic activity when infected with P. aeruginosa, whereas the percentage of surviving 
bacteria was significantly higher inside CF cells compared to the controls (del Porto P 2011). As 
AM in human CF lungs are highly activated by the inflammatory milieu, our group assessed 
the direct influence of CFTR on the function of AM by knockdown CFTR expression in normal 
human AM with siRNA silencing. A pro-inflammatory phenotype and increased apoptosis 
were seen in human AM with defective CFTR, possibly due to increased expression of the 
lipid raft protein Caveolin-1 (Xu Y 2010). The CFTR defect has been linked to augmented 
apoptosis with an abnormal cellular ceramide composition which is thought to be dependant 
on alteration in the lipid rafts in CF cells (Becker KA 2010). Altered pH of lysosome in CF 
macrophages has been suggested to induce defective acidification and bactericidal activity (Di 
A 2006). These findings have been disputed by others as the pH in the CF lysosomes was not 
altered using pH sensitive fluorescent probes (Haggie PM 2007 and 2009). 
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Macrophages may be part of an abnormal priming process in CF during fetal development. 
This has been suggested by the analysis of fetal lungs for early features of immune 
dysregulation, which showed that the number of macrophages in the lung was higher in CF 
fetal lungs compared to non-CF lungs during the later stages of lung development (Hubeau 
2001). Findings in the lungs of young infants with CF also point to the presence of increased 
macrophages as the macrophage recruiting CC chemokines elevated (Brennan S 2008; 
Starner 2003). 
2.2.3 Monocytes 
Peripheral blood monocytes, the precursors of AM, represent a pool of cells available to 
migrate to the lungs in response to bacterial infection. Abnormal functions of monocytes in 
peripheral blood from CF patients have been shown despite of absence of systemic infection 
in CF (del Fresno C 2008 and 2009, Sturges NC 2010, Zaman MM 2004). Augmented IL-8 
secretions at baseline and in response to LPS were seen in monocytes of adult subjects 
heterozygous for F508 mutation, with no increased expression of LPS receptors including 
CD14 and TLR4 but possible association with alterations in mitogen activated phosphate 
kinase (MAPK) signaling (Zaman MM 2004). Blood peripheral monocytes isolated from CF 
patients were found to be locked in an endotoxin tolerance state in comparison to those 
exacted from healthy volunteers, not due to a deficient TLR activation but likely resulted 
from down-regulation of Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) (del 
Fresno C 2008). Further investigation demonstrated potent phagocytic activity with 
impaired antigen presentation in LPS-tolerant monocytes from CF patients, possible by 
reason of decreased expression of MHCII and co-stimulatory molecules CD80, CD83, and 
CD86 (del Fresno C 2008). Contradictory to Zaman’s finding, Sturge et al. have shown 
enhanced expression of TLR4 but similar TLR2 levels in monocytes from young CF patients 
with median age of 3.3 compared to healthy controls (Sturges NC 2010). The conflicting 
results may be due to difference in the age of subjects, and longitudinal studies are required 
to determine TLR4 expression as CF lung disease progresses.   
2.2.4 Dendritic cells  
Dendritic cells (DC), the most potent antigen presenting cells, are critical at the interface of 
innate and adaptive immune response. It is not known if DC function is affected in CF in 
humans. Only one study assessed blood-derived DC from CF patients in their capacity to 
activate CD1d-restricted natural killer T cells (NKT cells). The finding was that CF and non 
CF DC could comparably stimulate NKT cells with no apparent impact from defective CFTR 
chloride channel function (Rzemieniak SE 2010). Normal murine bone marrow derived DC 
(BMDC) were cultured in sputum from CF patients. These DC showed down-regulated 
expression of co-stimulatory molecules CD40, CD80, and CD86 (but not MHCII), inhibited 
LPS-induced activation, and defective antigen-presenting ability, partially owing to the 
inflammatory mediator neutrophil elastase (Roghanian A 2006). In our study, BMDC from 
CF mice expressed CFTR but were delayed in the early phase of differentiation. The 
expression levels of a number of genes related to lipid metabolism including caveolin-1, 3β-
hydroxysterol-Δ7 reductase (Dhcr7), and stearoyl-CoA desaturase 2 (Scd2) were altered (Xu 
Y 2009). The roles of pulmonary DC, crucial in orchestrating innate and adaptive immune 
responses, have been investigated in lungs from CF mice in our laboratory (Xu Y 2009). 
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Phenotypic and functional abnormalities in CF lung DC were found including decreased 
numbers, altered maturation and activation profiles, and an impaired T cell-stimulation 
capacity. In response to respiratory syncytial virus infection, recruitment to the lung and T 
cell stimulatory potential of lung DC of CF mice were impaired in comparison to controls 
(Xu Y 2009). The dysfunctional CFTR might play a direct role in impaired lung DC. Indirect 
influence from the environment, where DC reside, on the phenotype and function of lung 
DC could not be excluded, although inflammation in lungs of CF mice at baseline is 
considerably mild compared to lungs of CF patients. Further investigation is undertaken to 
elucidate the mechanism of mal-functional DC in CF lungs. 
2.2.5 Lymphocytes 
Like the other immune cells, lymphocytes express CFTR and CF lymphocytes have a defective 
cAMP-regulated chloride channel function (Dong YJ 1995, McDonald TV 1992). B-lymphocytes 
from CF patients produced similar amounts of IgG compared to non-CF cells, but showed 
resistance to dexamethasone. This was proposed as a potential factor for the susceptibility to 
bacterial bronchopulmonary infections (Emilie D 1990). Selective cytokine dysregulation has 
been shown in CF CD4+ T cells after maximal activation with anti-CD3 or phorbol myristate 
acetate. It included decreased IFN- secretion and reduced IL-10 production, whereas the levels 
of IL-2, IL-4, and IL-5 remained similar to controls (Moss RB 1996 and 2000). IL-2 has been 
known to stimulate the growth, differentiation and survival of antigen-selected cytotoxic T cells. 
IL-4 is a cytokine that induces differentiation of naïve helper T cells (Th0 cells) to Th2 cells. The 
functions of IL-5 are to stimulate B cell growth and increase immunoglobulin secretion. 
Lymphocytes from CF patients or CF mice showed a profile skewed towards TH2 (Hartl D 
2005, Mueller C 2010). In CF patients with P. aeruginosa infection, the prevalence of a 
pulmonary TH2 immune response has been shown with higher levels of CCR4+CD4+ (TH2) 
cells, increased levels of IL-4, IL-13, and lower levels of IFN- compared with non-infected 
patients with CF and healthy controls (Hartl D 2005). Comparably, CF mice mounted an 
exaggerated IgE response upon Aspergillus fumigatus infection in the lung with increased 
levels of IL-4 and IL-13, mimicking both the TH2 biased immune responses seen in CF 
patients (Mueller C 2010). Similar findings are also reported in studies with peripheral blood 
derived monocytes or whole blood cultures from CF patients infected with P. aeruginosa 
(Brazova J 2005, Moser C 2000). A dysregulated TH1/2 response might contribute to the 
impaired clearance of pathogens in CF. 
Recently, more attention has been focused on the role of TH17 cells and interleukin-17 (IL-17) 
in the CF lung disease (McAllister F 2005, Tan HL 2011). IL-17 receptor signaling is critical 
for pulmonary neutrophil recruitment and host defense against Gram-negative bacteria 
through the coordinated release of granulocyte-colony stimulating factor (G-CSF) and CXC 
chemokine elaboration (Steinman L 2007, Bettelli 2007). Significantly elevated levels of IL-
17A, IL-17F and IL-17R were found in the sputum of patients with CF who were colonized 
with P. aeruginosa at the time of pulmonary exacerbation. These levels were declined with 
therapy directed against P. aeruginosa (McAllister F 2005). TH17 lymphocytes and other 
TH17+ cells, including neutrophils,  T cells, and natural killer T cells, have been shown to 
be present in the airway sub-mucosa in CF patients even in a young, newly diagnosed 
group. Highest levels of IL-17 were found in bronchoalveolar lavage from established CF 
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compared to the controls, with a significant correlation between IL-17 and neutrophil counts 
as well as IL-4 (Tan HL 2011). IL-17 pathway could serve as a new therapeutic candidate for 
CF, while the exact pathogenic mechanisms of IL-17 in CF still remain to be elucidated. 
3. Conclusion 
Augmented inflammation, increased susceptibility of the respiratory tract for infections and 
lack of efficient clearance of the pathogens are features of a defective immune function. 
Abnormal CFTR chloride channel function (and potentially associated sodium 
hyperabsorption) in epithelial and mucous gland cells in the lung can only partially explain 
the pathophysiology of CF lung disease. Members of the innate and adaptive immune 
system are clearly affected by the milieu created by the altered salt and water composition. 
There is also evidence that CFTR dysfunction directly affects immune responses, probably 
beyond the stimulation of inflammatory cytokines. CFTR is expressed and is functional in a 
variety of immune cells. CFTR-related abnormalities have been shown in neutrophils, 
macrophages, monocytes, dendritic cells, and lymphocytes independent of exposure to the 
CF milieu of the respiratory tract as demonstrated in Fig 1. Thus, direct CFTR-mediated 
dysfunction of these cells may play a role in the enigmatic CF lung disease.  
 
Fig. 1. Model of abnormal humoral and cellular immune responses in the CF lung. Altered 
humoral responses are comprised of soluble mediators including cytokines, chemokines, 
antioxidants, and antiproteases. Neutrophils, macrophages, dendritic cells, and lymphocytes 
are either affected by the altered soluble mediators from the CFTR-deficient epithelial and 
immune cells or by their own defective CFTR function.  
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